On November 3, 2025, Iradimed CEO Roger E. Susi sold 5,000 shares, representing about 1% of his total holdings. The transaction was valued at approximately $413,216 based on a weighted average price of $82.64 per share. Despite the sale, Susi still holds over 2.2 million shares indirectly. Iradimed, a medical device company, reported a 72.4% price increase over the past year, with third-quarter revenue rising by 16% to $21.2 million. The company’s full-year sales outlook has been raised to $83 million, reflecting a 13.4% increase in 2025. This sale is not likely an indication of trouble with Iradimed’s business.

Read more at Nasdaq: Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216